Addgene: Molecular Therapy Interview with Melina Fan and Karen Guerin

Luk H. Vandenberghe
DOI: https://doi.org/10.1016/j.ymthe.2018.12.001
IF: 12.91
2019-01-01
Molecular Therapy
Abstract:Addgene, a non-profit based in Cambridge, MA in the USA, is well-known for its plasmid repository and distribution services to academics worldwide. In the fall of 2018, they reached a major milestone by having shared over 1,000,000 plasmids. Recently, they also ventured into a new service: the distribution of viral vector preparations. Because of these events, Molecular Therapy decided to sit down with Melina Fan, Chief Scientific Officer, who helped co-found Addgene, and Karen Guerin, Associate Director of Viral Vectors. Luk H. Vandenberghe, Deputy Editor for Molecular Therapy, asked about Addgene’s history, the roll-out of its viral vector services, and the interfaces of Addgene with the world of gene transfer and cell and gene therapy.
genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
What problem does this paper attempt to address?